VXRT · Vaxart, Inc. · Investor Relations
$0.32
+0.00 (+0.00%)
At close · Jul 8
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on management's current plan, the Company expects to have enough cash runway into the second quarter of 2027. If the Company is unable to raise additional capital in sufficient amounts or on acceptable terms, management's plans include further reducing or delaying operating expenses. These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the date of the issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$126.27M
Shares
242.84M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-07 | Vaxart, Inc. Q2 2026 Stockholder Fireside Chat | Shareholder meeting |
| 2026-05-08 | Vaxart, Inc. Q1 2026 Stockholder Fireside Chat | Shareholder meeting |
| 2026-05-08 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-13 | Vaxart, Inc. Stockholder Fireside Chat | Shareholder meeting |
| 2026-03-12 | Vaxart, Inc. Full Year 2025 Business Update and Financial Results Conference Call | Earnings call |
| 2026-02-25 | Oppenheimer 36th Annual Healthcare Life Sciences Conference | Conference |
| 2026-01-13 | Vaxart to Participate in the Global BioInnovation | Event |
| 2025-11-18 | Vaxart, Inc. Stockholder Fireside Chat | Shareholder meeting |
| 2025-11-13 | Vaxart, Inc. Third Quarter 2025 Business Update and Financial Results Conference Call | Earnings call |
Source: https://investors.vaxart.com/